Search Within

MSK Grad Students

Formats
  1. Journal Article (1685)
  2. Meeting Abstract (991)
  3. Review (110)
  4. Editorial (43)
  5. Research Letter (37)
  6. Miscellaneous (21)
  7. Correspondence (15)
  8. Conference Paper (12)
  9. Book Section (9)
  10. Guidelines (6)
Groups
  1. GSK Faculty (2053)
  2. Department of Medicine (1647)
  3. Sloan Kettering Institute Postdocs (1633)
  4. Sloan Kettering Institute Faculty (1330)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1201)
  6. Center for Hematologic Malignancies (1143)

More Groups

People
  1. Sergio Giralt (401)
  2. Miguel-Angel Perales (386)
  3. Parastoo Dahi (305)
  4. Sean Devlin (286)
  5. Doris Ponce (257)
  6. Roni Tamari (214)

More People

Years
  1. 2025 (163)
  2. 2024 (275)
  3. 2023 (313)
  4. 2022 (334)
  5. 2021 (289)
  6. 2020 (378)

More Years

Publications
  1. Blood (311)
  2. Biology of Blood and Marrow Transplantation (165)
  3. Cancer Research (133)
  4. Journal of Clinical Oncology (130)
  5. Nature Communications (96)
  6. Nature (89)

More Publications

Publishers
  1. Nature Publishing Group (447)
  2. American Society of Hematology (350)
  3. Elsevier Inc. (299)
  4. Cell Press (280)
  5. American Association for Cancer Research (269)
  6. American Society of Clinical Oncology (149)

More Publishers

Results (2929)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial
    Meeting Abstract

    Rajeeve, S.; Derkach, A.; Devlin, S. M.; Santos, J.; Przemielewska, A.; Sood, T.; Maclachlan, K. H.; Hashmi, H.; Tan, C. R.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A Proof-of-principle of split-course bridging radiotherapy (SC-BRT) prior to CAR T-cell therapies for relapsed or refractory B-cell lymphomas: A phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K. K.; Boardman, A. P.; Dahi, P. B.; Shah, G. L.; Scordo, M.; Park, J. H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Very low dose radiotherapy (VLDRT) with 4 Gy for potentially-curable indolent non-Hodgkin lymphomas
    Meeting Abstract

    Mankuzhy, N. P.; Imber, B. S.; Pammer, P.; Fregonese, B.; Cajo, A.; Cederquist, G.; Dreyfuss, A.; Lapen, K.; Patel, R. R.; Moore, Z. R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • When can we define cure after CAR-T therapy in LBCL? insights from serial landmark analyses
    Meeting Abstract

    Gomez-Llobell, M.; Shouval, R.; Brown, S.; Accav, N. G.; Devlin, S. M.; Corona, M.; Rejeski, K.; Rivas-Delgado, A.; Luna, A.; Luttwak, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Effector differentiation and exhaustion attenuate on-target, off-tumor toxicity of CD24 CAR T cells
    Meeting Abstract

    Boardman, A. P.; Rajagopalan, A.; Chen, S.; Ng, B.; Fischman, J.; Massa, A.; Elias, H. K.; Manuele, D.; Atmane, M. I.; Miranda, I.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Regulatory T cell derived trefoil factor 1 drives thymic regeneration in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Pierce, J.; Gipson, B.; Serrano-Marin, L.; Argyropoulos, K.; Dewolf, S.; James, S. E.; Kaur, M.; Kousa, A.; Nguyen, C. L.; Rajagopalan, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Systematic evaluation of GAPs and GEFs identifies ARHGAP45 as a targetable leukemia-specific dependency
    Meeting Abstract

    Zhang, P.; Cao, Z.; Pan, X.; Liu, Y.; Castro, C.; Kim, W. J.; Fujino, T.; Lewis, J.; Rahman, J.; Shahid, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Prediction of post-transplant relapse of the myelodysplastic syndromes via evaluation of stem cells
    Meeting Abstract

    Kroger, B.; Tamari, R.; Gurnari, C.; Thiebaud, J. A.; Velarde, A. M.; Madanat, Y. F.; Collins, R. H.; Jackson, C.; Gatell, V. I.; Visconte, V.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Phase II study of longitudinal geriatric assessment with risk-adapted interventions to reduce non-relapse mortality in allogeneic hematopoietic cell transplantation for older patients with advanced myeloid malignancies
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Brown, S.; Hanley, D. M.; Engstler, D. E.; Politikos, I.; Gyurkocza, B.; Tamari, R.; Papadopoulos, E. B.; Saldia, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The Composite Health Risk Assessment Model (CHARM) predicts risks of toxicities, functional and cognitive decline among survivors of allogeneic hematopoietic cell transplantation (allo-HCT): A prospective BMT-CTN study 1704
    Meeting Abstract

    Sorror, M.; Saber, W.; Logan, B. R.; Geller, N.; Bellach, A.; Kou, J.; Wood, W. A.; McCarty, J. M.; Knight, T. G.; Runaas, L.; more...
    Blood (2024)

    Fulltext@MSK | Save